FDA pharmacologic class
Antisense Oligonucleotide
7 medicines are in FDA's class of antisense oligonucleotides: eteplirsen (Exondys), nusinersen (Spinraza), eplontersen (Wainua), olezarsen (Tryngolza), casimersen (Amondys), golodirsen (Vyondys) and tofersen (Qalsody). 0 of the 7 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are antisense oligonucleotide?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Eteplirsen | Exondys | none listed | n/a | No | No current entry | 0 |
| Nusinersen | Spinraza | none listed | n/a | No | No current entry | 0 |
| Eplontersen | Wainua | none listed | n/a | No | No current entry | 0 |
| Olezarsen | Tryngolza | none listed | n/a | No | No current entry | 0 |
| Casimersen | Amondys | none listed | n/a | No | No current entry | 0 |
| Golodirsen | Vyondys | none listed | n/a | No | No current entry | 0 |
| Tofersen | Qalsody | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)